암환자를 위한 정신약물요법의 개요
Overview of Psychopharmacotherapy for Cancer Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cancer patients experience various physical and psychological symptoms, which can be alleviated by psychotropic medications. In the process of developing the recommendations for distress management in cancer patients, the Korean psycho-oncology research group performed systematic reviews on the oncological psychopharmacotherapy literature. This study describes the general principles and some practical suggestions.
Abstract
Cancer patients experience various physical and psychological symptoms, which can be alleviated by psychotropic medications. In the process of developing the recommendations for distress management in cancer patients, the Korean psycho-oncology research group performed systematic reviews on the oncological psychopharmacotherapy literature. This study describes the general principles and some practical suggestions.
참고문헌 (17)
- "clinical practice guidelines in oncology. Distress management. v.1"[URL]
- Yi MS, "Focus group study on the psychosocial distress of cancer patients in Korea. J Korean Acad Adult Nurs. In press 2009", ~ (2009)
- Zabora J, "The prevalence of psychological distress by cancer site", Psychooncology, 10, pp.19~28 (2001)
- Carlson L, "High levels of untreated distress and fatigue in cancer patients", Br J Cancer, 90, pp.2297~2304 (2004)
- Ministry of Health & Welfare, "Development of recommendations for distress management toward improvement of quality of life in cancer patients", ~ (2008)
- 함봉진, "정신종양학의 역사와 현황", 신경정신의학, 46(5), pp.413~420 (2007), 대한신경정신의학회
- 조성진, "암 환자와 가족에 대한 정신의학적 · 심리사회적 개입", 신경정신의학, 46(5), pp.430~446 (2007), 대한신경정신의학회
- National Institute for Clinical Excellence, "Guideline development methods: information for national collaborating centres and guideline developers" (2005), National Institute for Clinical Excellence
- Yu ES, "Development of Korean recommendations for distress management of cancer patients", Annual Conference of American Psychosocial Oncology Society (2010), American Psychosocial Oncology Society
- Scottish Intercollegiate Guideline Network, "A guideline developer’s handbook" (2002), Scottish Intercollegiate Guideline Network
- Peterson LG, "Psychotropic medications in patients with cancer", Gen Hosp Psychiatry, 9, pp.313~323 (1987)
- Berney A, "Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants", Support Care Cancer, 8, pp.278~286 (2000)
- Quick Reference for Oncology Clinicians, "The psychiatric and psychological dimensions of cancer symptom management" (2006), IPOS Press
- Stiefel FC, "Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period", Cancer, 65, pp.1048~1053 (1990)
- Buclin T, "Psychopharmacology in supportive care of cancer: a review for the clinician. IV. Other psychotropic agents", Support Care Cancer, 9, pp.213~222 (2001)
- Lloyd-Williams M, "A survey of antidepressant prescribing in the terminally ill", Palliat Med, 13, pp.243~248 (1999)
- Bruera E, "The uses of psychotropics in symptom management in advanced cancer", Psychooncology, 7, pp.346~358 (1998)